Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of salmeterol/fluticasone inhalation powder in adult asthma
CTR20252491Phase 3Active
- Sponsor
- Zhixing Pharmaceutical
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by Zhixing Pharmaceutical. Started Sep 2025; status: active.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20252491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252491.